cardiovascular (heart) disease Archive — Page 2 of 8
-
April 17, 2024
Common AFib drug linked to higher bleeding risk
In a national retrospective study led by researchers at Vanderbilt University School of Medicine, diltiazem, when given in combination with the anticoagulant drugs apixaban (Eliquis) or rivaroxaban (Xarelto), significantly increased the risk of serious bleeding compared to metoprolol. -
April 9, 2024
Lifting up voices to celebrate healthy Black births
Celebration of Black Motherhood on April 20 elevates positive stories and experiences around Black births -
April 9, 2024
Heart disease, depression linked by inflammation: study
Coronary artery disease and major depression may be genetically linked via inflammatory pathways to an increased risk for cardiomyopathy, a degenerative heart muscle disease, researchers at Vanderbilt University Medical Center and Massachusetts General Hospital have found. -
April 3, 2024
Excess salt linked to heart disease deaths in low-income group: study
Excessive consumption of dietary sodium likely was responsible for up to 30% of cardiovascular disease-related deaths among mostly low-income participants in a large cohort study conducted by Vanderbilt University Medical Center. -
March 18, 2024
Bariatric surgery linked to cardiometabolic health improvements: study
Bariatric surgery can lead to significant cardiometabolic health improvements using a variety of measures, including blood pressure, cholesterol, glucose and hemoglobin A1C, according to a new study published in the Journal of the Endocrine Society. -
March 6, 2024
New toolkit helps non-obstetricians better identify and treat pregnant and postpartum patients with cardiovascular emergencies
Vanderbilt's Kathryn Lindley, MD, has worked with the American College of Obstetricians and Gynecologists and the Centers for Disease Control and Prevention to develop a national toolkit for non-obstetricians to better identify and treat pregnant and postpartum patients with cardiovascular emergencies. -
February 20, 2024
System offers new option to treat mitral regurgitation
In a novel procedure, the Vanderbilt Heart & Vascular Institute (VHVI) successfully performed the first large-flange Innovalve transcatheter mitral valve replacement.